Subscribe to Drug Discovery & Development News

The Lead

AstraZeneca Cancer Drug, Companion Test Approved

December 19, 2014 | by Linda A. Johnson - AP Business Writer | Comments

U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from AstraZeneca. Read more...                 

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Eli Lilly, University of Surrey Announce Diabetes Research Partnership

December 22, 2014 3:15 pm | Comments

Eli Lilly announced a five-year research partnership with the University of Surrey to study health outcomes, focusing on the effects of treatment in people with type 2 diabetes. Read more...            


High Doses of Vancomycin Fuel Risk of Kidney Damage in Children

December 22, 2014 3:01 pm | by Johns Hopkins University | Comments

A new study shows that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage. Read more...          


AbbVie's Hepatitis C Treatment Gains FDA Approval

December 22, 2014 2:42 pm | by Linda A. Johnson - AP Business Writer | Comments

Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie. Read more...               


Mylan Launches First Generic Version of Menopause Treatment

December 22, 2014 12:57 pm | Comments

Mylan received final approval from the FDA for this product. Read more...                               


FDA Approves Cubist Antibiotic for Serious Infections

December 22, 2014 12:43 pm | by Linda A. Johnson - AP Business Writer | Comments

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract. Read more...                     


Juno Therapeutics Stock Surges in Market Debut

December 22, 2014 12:27 pm | by Associated Press | Comments

Amazon CEO Jeff Bezos is one of Juno's primary investors. Read more...                                 


Express Scripts, AbbVie Make Huge Hepatitis C Deal

December 22, 2014 12:18 pm | by Tom Murphy - AP Business Writer | Comments

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C. Read more...                    


Research Suggests Riluzole May Prevent Foggy 'Old Age' Brain

December 22, 2014 9:26 am | by Rockefeller University | Comments

Researchers found they could stop normal, age-related memory loss in rats by treating them with riluzole. Read more...                        


WHO: Recorded Ebola Deaths Top 7,000

December 22, 2014 8:54 am | by Boubacar Diallo - Associated Press | Comments

The worst Ebola outbreak on record has now killed more than 7,000 people. Read more...                             


FDA Approves Myriad's PARP Inhibitor for Ovarian Cancer

December 19, 2014 2:08 pm | Comments

Myriad Genetics, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for BRACAnalysis CDx to be used as the only companion diagnostic in conjunction with AstraZeneca’s drug Lynparza (olaparib). Read more...


After Lung Transplant, Antiviral Drug Resistance More Likely in Cystic Fibrosis

December 19, 2014 1:50 pm | Comments

A drug called ganciclovir is given to lung transplant patients to protect against a life-threatening virus that is common after transplantation. Read more...                                                     


Putting the Breaks on Cancer

December 19, 2014 1:38 pm | Comments

A study led by the University of Dundee, in collaboration with the University of Bath, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how it combats the effects of mutations which drive cancer development. Read more...


Combo Drug Therapy Doubles Positive Effect for Women with Breast Cancer

December 19, 2014 1:20 pm | Comments

In a groundbreaking study that offers new hope for women with advanced breast cancer, UCLA researchers published final clinical trial results that showed the amount of time women with advanced breast cancer were on treatment without their cancer worsening was effectively doubled when they took the experimental drug palbociclib. Read more...


Market for Testing On Tissues, Cells Reaches $7.5B

December 19, 2014 1:06 pm | Comments

Driven by new technologies and the need to discover biomarkers, the tissue and cell-based diagnostic market grew to an estimated 7.4 billion in revenues in 2013 for in vitro diagnostic (IVD) and other reagents used by clinical laboratories. Read more...


UN Chief Visits Ebola-Ravaged West African Nations

December 19, 2014 10:18 am | by Jonathan Paye-Layleh - Associated Press | Comments

United Nations Secretary-General Ban Ki-moon praised Liberia on its efforts to combat Ebola on Friday. Read more...                        



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.